###begin article-title 0
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
IBD-Associated TL1A Gene (TNFSF15) Haplotypes Determine Increased Expression of TL1A Protein
###end article-title 0
###begin p 1
###xml 288 296 <span type="species:ncbi:9606">patients</span>
Conceived and designed the experiments: KSM LST DM JIR SRT. Performed the experiments: KSM LST KDT QTY LM CL. Analyzed the data: KSM LST KDT QTY LM CL CD. Contributed reagents/materials/analysis tools: CL. Wrote the paper: KSM KDT DM JIR SRT. Coordinated the research study and recruited patients: CD.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 282 286 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
The recently identified member of the TNF superfamily TL1A (TNFSF15) increases IFN-gamma production by T cells in peripheral and mucosal CCR9+ T cells. TL1A and its receptor DR3 are up-regulated during chronic intestinal inflammation in ulcerative colitis and Crohn's disease (CD). TL1A gene haplotypes increase CD susceptibility in Japanese, European, and US cohorts.
###end p 3
###begin title 4
Methodology and Principal Findings
###end title 4
###begin p 5
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
###xml 364 368 362 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 124 131 <span type="species:ncbi:562">E. coli</span>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
###xml 261 269 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 625 633 <span type="species:ncbi:9606">patients</span>
Here we report that the presence of TL1A gene haplotype B increases risk in Jewish CD patients with antibody titers for the E. coli outer membrane porin C (OmpC+) (Haplotype B frequency in Jewish CD patients: 24.9% for OmpC negative and 41.9% for OmpC positive patients, respectively, P</=0.001). CD14+ monocytes isolated from Jewish OmpC+ patients homozygous for TL1A gene haplotype B express higher levels of TL1A in response to FcgammaR stimulation, a known inducing pathway of TL1A, as measured by ELISA. Furthermore, the membrane expression of TL1A is increased on peripheral monocytes from Jewish but not non-Jewish CD patients with the risk haplotype.
###end p 5
###begin title 6
Conclusions and Significance
###end title 6
###begin p 7
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
###xml 127 135 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
These findings suggest that TL1A gene variation exacerbates induction of TL1A in response to FcgammaR stimulation in Jewish CD patients and this may lead to chronic intestinal inflammation via overwhelming T cell responses. Thus, TL1A may provide an important target for therapeutic intervention in this subgroup of IBD patients.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Migone1">[1]</xref>
###xml 302 303 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 315 318 311 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Bamias1">[2]</xref>
###xml 320 323 316 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Papadakis1">[3]</xref>
###xml 325 328 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Papadakis2">[4]</xref>
###xml 461 464 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Bamias1">[2]</xref>
###xml 466 469 462 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn1">[5]</xref>
###xml 627 630 623 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Papadakis1">[3]</xref>
###xml 632 635 628 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Papadakis2">[4]</xref>
###xml 725 728 721 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Bamias2">[6]</xref>
###xml 236 241 <span type="species:ncbi:9606">human</span>
###xml 409 417 <span type="species:ncbi:9606">patients</span>
###xml 640 646 <span type="species:ncbi:10090">murine</span>
TL1A, a recently identified member of the TNF superfamily, increases IL-2 response by anti-CD3/CD28-stimulated T cells [1]. Furthermore, we and others have shown that TL1A synergizes with IL-12 and IL-18 to augment IFN-gamma release in human T and NK cells and biases T cell differentiation towards a TH1 phenotype [2], [3], [4]. TL1A expression is increased in inflamed tissue of colon and small bowel of CD patients and colocalizes to macrophages and T cells [2], [5]. In particular, lamina propria, but also peripheral CD4+CCR9+ T cells, constitutively express membrane TL1A and are especially sensitive to TL1A stimulation [3], [4]. In murine models of ileitis, TL1A is mainly expressed on lamina propria dendritic cells [6].
###end p 9
###begin p 10
###xml 232 235 228 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn2">[7]</xref>
###xml 335 338 331 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Migone1">[1]</xref>
###xml 340 343 336 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn2">[7]</xref>
###xml 456 457 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 464 465 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 565 568 561 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Takedatsu1">[8]</xref>
###xml 795 798 791 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Fang1">[9]</xref>
###xml 800 804 796 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Meylan1">[10]</xref>
###xml 806 810 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Pappu1">[11]</xref>
###xml 405 411 <span type="species:ncbi:10090">murine</span>
We have recently demonstrated that TL1A is produced by antigen-presenting cells, e.g. monocytes and dendritic cells, in response to FcgammaR signaling but not in response to Toll-like receptor agonists or pro-inflammatory cytokines [7]. Stimulation with Immune Complexes (IC) leads to the expression of both membrane and secreted TL1A [1], [7]. Neutralizing TL1A antibodies prevent and treat colitis in a murine model of chronic colitis by affecting both TH1 and TH17 responses, suggesting that TL1A is a central regulator of intestinal inflammation during colitis [8]. In addition, it has been demonstrated recently that TL1A also plays an important role in the pathogenesis of other inflammatory diseases, such as Experimental Autoimmune Encephalomyelitis (EAE) and allergic lung inflammation [9], [10], [11].
###end p 10
###begin p 11
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Yamazaki1">[12]</xref>
###xml 202 206 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Kakuta1">[13]</xref>
###xml 233 240 233 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 291 302 291 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 320 331 320 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Yamazaki1">[12]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Kakuta1">[13]</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Barrett1">[14]</xref>
###xml 478 489 478 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 520 524 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 586 597 586 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 800 811 800 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 843 847 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 1052 1056 1052 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Funke1">[16]</xref>
###xml 1058 1062 1058 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Li1">[17]</xref>
###xml 1064 1068 1064 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Ober1">[18]</xref>
###xml 1070 1074 1070 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Silverberg1">[19]</xref>
###xml 1076 1080 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Sugimura1">[20]</xref>
###xml 1082 1086 1082 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Tountas1">[21]</xref>
###xml 1088 1092 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-VanDenBogaert1">[22]</xref>
###xml 1126 1145 1126 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 haplotype B</italic>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 1314 1321 1314 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1353 1357 1353 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Mow1">[23]</xref>
###xml 1359 1363 1359 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Arnott1">[24]</xref>
###xml 1423 1430 1423 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 1104 1112 <span type="species:ncbi:9606">patients</span>
###xml 1314 1321 <span type="species:ncbi:562">E. coli</span>
###xml 1468 1476 <span type="species:ncbi:9606">patients</span>
The first genome-wide association study of CD provided evidence that variation in TNFSF15, the TL1A gene, contribute to CD in Japanese and both CD and ulcerative colitis in the British population [12], [13]. Haplotypes composed of 5 TNFSF15 SNPs were observed to confer significant CD risk (haplotype A) and protection (haplotype B), using both case/control and family-based study designs [12], [13], [14]. We have also observed a protective association between CD and the same haplotype B in a Los Angeles based cohort [15]. Stratification on Ashkenazi Jewish ethnicity suggested that haplotype B may have a different effect on CD susceptibility in the Jewish and non-Jewish populations. In contrast to the protective association seen in non-Jews, the opposite trend towards a risk association with haplotype B was observed in Ashkenazi Jews [15]. Similar observation of differential genetic risk association in diverse ethnic groups have been made in CD, in ulcerative colitis and other gentically complex diseases including schizophrenia and asthma [16], [17], [18], [19], [20], [21], [22]. Jewish CD patients carrying the TNFSF15 haplotype B were more likely to have more severe CD, as evidenced by a higher rate of surgery [15] and by the expression of antibody responses to microbial antigens, including the E. coli outer membrane porin C (OmpC+) [23], [24]. To date, no functional basis for the relationship between TNFSF15 variation and disease severity in CD patients has been shown.
###end p 11
###begin p 12
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 143 161 143 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 haplotypes</italic>
###xml 258 277 258 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 haplotype B</italic>
###xml 410 417 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 423 434 419 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 605 612 601 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
###xml 392 400 <span type="species:ncbi:9606">patients</span>
###xml 676 684 <span type="species:ncbi:9606">patients</span>
###xml 801 809 <span type="species:ncbi:9606">patients</span>
In order to determine the functional consequences of TNFSF15 genetic variation, we have identified subjects for immunological studies based on TNFSF15 haplotypes. Here we show that, in Jewish CD patients with seropositivity for OmpC, the TL1A risk haplotype TNFSF15 haplotype B is associated with higher TL1A expression upon stimulation of FcgammaR. Furthermore, Jewish but not non-Jewish CD patients with the TNFSF15 risk haplotype B have a higher baseline expression of TL1A on peripheral monocytes, suggesting a higher baseline capacity for T cell stimulation. Collectively, our data define a role for TNFSF15 genetic variation in determining disease severity in Jewish CD patients, and support the concept that TL1A is a novel interventional target, at least for the subgroup of Jewish, OmpC+, CD patients.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subjects
###end title 14
###begin p 15
###xml 519 526 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004719-t001">Table 1</xref>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Roth1">[25]</xref>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Yang1">[26]</xref>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 292 300 <span type="species:ncbi:9606">patients</span>
###xml 424 431 <span type="species:ncbi:9606">patient</span>
###xml 773 781 <span type="species:ncbi:9606">patients</span>
We collected peripheral blood from randomly selected patients attending the IBD center at Cedars-Sinai Medical Center who had previously been diagnosed with CD according to standard clinical, endoscopic, radiological, and histological findings. Written informed consent was obtained from all patients. Procedures were approved by the Institutional Review Board of Cedars-Sinai Medical Center (IRB number 3358 and 2673). The patient's demographics, diagnoses and medications at time of sample collection are provided in Table 1. The medications were equivalent in the different groups. Jewish ethnicity was defined as previously described by one or more grandparents of Ashkenazi Jewish descent [25], [26]. Controls were matched for ethnicity and were usually spouses of CD patients.
###end p 15
###begin title 16
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient's demographic, diagnoses, medications.
###end title 16
###begin title 17
TNFSF15 genotyping and haplotype assignment
###end title 17
###begin p 18
###xml 39 81 39 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3810936, rs6478108, rs6478109, rs7848647</italic>
###xml 87 96 87 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7869487</italic>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Fan1">[27]</xref>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Shen1">[28]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Kutyavin1">[29]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Livak1">[30]</xref>
###xml 377 467 377 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs3810936, hCV363308; rs6478108, hCV170492; rs6478109, hCV1305297; rs7848647, hCV11277159;</italic>
###xml 472 494 472 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rs7869487, hCV11277149</italic>
###xml 678 685 678 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 748 756 748 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g001">Figure 1</xref>
###xml 810 818 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g001">Figure 1</xref>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Yamazaki1">[12]</xref>
###xml 1038 1042 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Kakuta1">[13]</xref>
###xml 1044 1048 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
Single nucleotide polymorphisms (SNPs) rs3810936, rs6478108, rs6478109, rs7848647, and rs7869487 were genotyped using either Illumina Golden Gate technology [27], [28] or ABI TaqMan MGB technology [29], [30] following the manufacturer's protocols (Illumina, San Diego, CA; ABI, Foster City, CA). Assays for these SNPs are available to other researchers through ABI as follows: rs3810936, hCV363308; rs6478108, hCV170492; rs6478109, hCV1305297; rs7848647, hCV11277159; and rs7869487, hCV11277149. Consistency between the two methods has been confirmed in our laboratory by genotyping over 200 samples with both methods. Details of the positions of these SNPs with respect to the TNFSF15 gene and the haplotypes from the individual SNPs are shown in Figure 1. While redundancy in the 5 SNPs may be apparent from Figure 1, all 5 SNPs are retained in this study in order to (1) distinguish the major haplotypes from minor haplotypes with low frequencies (data not shown) and (2) retain the haplotype terminology of the previous reports [12], [13], [15]. Haplotypes were assigned from the individual SNP data using Phase v2 and the probability of assignment was greater than 95%. Association of haplotypes with the presence of antibody per subject was tested by chi-square and the significance was estimated by permutation (Jewish OmpC-: N = 304, Jewish OmpC+: N = 196, non-Jewish OmpC-: N = 434, non-Jewish OmpC+: N = 234).
###end p 18
###begin title 19
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A (TNFSF15)</italic>
TL1A (TNFSF15) gene and haplotype structure and association with Crohn's Disease.
###end title 19
###begin p 20
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 101 113 101 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">chromosome 9</italic>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Yamazaki1">[12]</xref>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 674 682 <span type="species:ncbi:9606">patients</span>
###xml 762 770 <span type="species:ncbi:9606">patients</span>
(A) The TNFSF15 gene is on the reverse strand of NCBI human genome build 36 at the position shown on chromosome 9 but is shown 5' to 3' in keeping with the previous reports. The dotted line represents genomic sequence, solid line the gene sequence, thin bars untranslated regions, and thick bars the exons. (B) Single nucleotide polymorphisms (SNPs) genotyped for this study are listed with their relative positions along the gene. (C) Definition of haplotypes assigned in this study. The nucleotide assignments follow the previous report and correspond to the sense strand of the gene. The numbers 26, 31, 35, 36, and 41 refer to previous reports [12]. (D) Frequency of CD patients as a function of OmpC status for TL1A haplotype B for Jewish and non-Jewish CD patients, respectively (P</=0.001).
###end p 20
###begin title 21
Serological Analysis
###end title 21
###begin p 22
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Landers1">[31]</xref>
Sera were analyzed for expression of anti-OmpC antibodies by ELISA as previously described [31].
###end p 22
###begin title 23
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 34 41 <span type="species:ncbi:9606">patient</span>
Isolation of CD14+ monocytes from patient's blood
###end title 23
###begin p 24
###xml 204 207 204 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn2">[7]</xref>
###xml 24 32 <span type="species:ncbi:9606">patients</span>
Blood was obtained from patients after informed consent in accordance with procedures established by the Cedars-Sinai Institutional Review Board. Monocytes were isolated from PBMC as described previously [7].
###end p 24
###begin title 25
Cell culture and stimulation
###end title 25
###begin p 26
###xml 78 81 78 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn2">[7]</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
Plate-bound, cross-linked human IgG (IC) was prepared as described previously [7]. Monocytes were incubated with IC for the indicated time-points.
###end p 26
###begin title 27
ELISA
###end title 27
###begin p 28
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn2">[7]</xref>
TL1A was quantified in undiluted supernatants from stimulated cells using an ELISA and Ab developed at Teva Pharmaceutical USA as described elsewhere [7].
###end p 28
###begin title 29
Flow cytometry
###end title 29
###begin p 30
###xml 104 107 104 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn2">[7]</xref>
Monocytes stimulated with IC or bacteria for 16 h were stained with the TL1A Ab as described previously [7]. Cells were analyzed on a CyAntrade mark ADP flow cytometer (Dako Cytomation, Carpinteria, CA) and analyzed with the Summit 4.1 software package (Dako).
###end p 30
###begin title 31
Statistics
###end title 31
###begin p 32
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical significance between groups was determined by Student's t test. A value of p</=0.05 was considered to be statistically significant.
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
###xml 15 41 15 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 (TL1A) haplotype B</italic>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Association of TNFSF15 (TL1A) haplotype B and the serum expression of anti-OmpC in Jewish Crohn's disease patients
###end title 34
###begin p 35
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Mow1">[23]</xref>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Arnott1">[24]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Mei1">[32]</xref>
###xml 160 179 160 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 haplotype B</italic>
###xml 266 277 266 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g001">Figure 1A&#8211;D</xref>
###xml 280 298 280 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 haplotypes</italic>
###xml 394 405 394 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g001">Figure 1A&#8211;C</xref>
###xml 514 525 514 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 618 627 618 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g001">Figure 1D</xref>
###xml 749 753 749 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 808 819 808 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 909 919 909 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g001">Figure 1 D</xref>
###xml 993 1004 991 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1148 1152 1146 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 1154 1163 1152 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g001">Figure 1D</xref>
###xml 1227 1253 1225 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 (TL1A) haplotype B</italic>
###xml 1410 1421 1408 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1514 1525 1510 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1573 1584 1569 1580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1771 1782 1767 1778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
###xml 1335 1343 <span type="species:ncbi:9606">patients</span>
###xml 1393 1401 <span type="species:ncbi:9606">patients</span>
###xml 1500 1508 <span type="species:ncbi:9606">patients</span>
###xml 1559 1567 <span type="species:ncbi:9606">patients</span>
###xml 1820 1828 <span type="species:ncbi:9606">patients</span>
Since the expression of anti-OmpC in CD patients is a familial trait and has been associated with severe CD [23], [24], [32], we tested the association between TNFSF15 haplotype B and the serum expression of anti-OmpC in Ashkenazi Jewish and non-Jewish CD patients (Figure 1A-D). TNFSF15 haplotypes were assigned from individual SNP data using PHASE v2 with a probability greater than 95% (see Figure 1A-C for details of SNPs and haplotypes). In non-Jewish CD subjects, there was no difference in the frequency of haplotype B between OmpC positive and OmpC negative subjects (OmpC negative 38.6%, OmpC positive 38.3%; Figure 1D). The frequency of haplotype B in either group was similar to that previously observed for all CD in non-Jewish subjects [15]. In contrast, for Jewish CD subjects the frequency of haplotype B was significantly higher in OmpC positive subjects compared with OmpC negative subjects (Figure 1 D) (24.9% OmpC negative, 41.9% OmpC positive, P</=0.001). The frequency of haplotype B in OmpC negative subjects was lower and in OmpC positive subjects was higher than that previously observed for all CD in Jewish subjects (32%) [15] (Figure 1D). In addition, the level of anti-OmpC expression was higher in TNFSF15 (TL1A) haplotype B Jewish subjects (the median level of anti-OmpC was 23.9 ELISA units in Jewish CD patients with haplotype B compared with 14.9 in Jewish CD patients without haplotype B, P wilcoxon test </=0.001). The frequency of OmpC seropositivity in Jewish CD patients with haplotype B is 52%, and 36% in non-Jewish CD patients with haplotype B. We did not observe an association between other CD-associated antibodies to microbial antigens (e.g. anti-Cbir1 antibodies, anti-I2 antibodies, anti-ASCA antibodies) and differences in haplotype B frequency in Jewish or non-Jewish CD patients (data not shown).
###end p 35
###begin title 36
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 (TL1A) haplotypes</italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
TNFSF15 (TL1A) haplotypes in Jewish IBD patients results in differential TL1A expression in monocytes stimulated with IC
###end title 36
###begin p 37
###xml 30 55 30 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 (TL1A) haplotypes</italic>
###xml 225 237 225 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotypes A</italic>
###xml 241 242 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 332 335 332 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn2">[7]</xref>
###xml 412 423 412 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 475 486 475 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 549 560 549 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 571 580 571 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g002">Figure 2A</xref>
###xml 682 693 682 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 706 717 706 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 735 744 735 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g002">Figure 2A</xref>
###xml 841 853 841 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotypes A</italic>
###xml 858 859 858 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 886 895 886 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g002">Figure 2B</xref>
###xml 898 909 898 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haplotype B</italic>
###xml 971 982 971 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1133 1144 1133 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1267 1278 1267 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1296 1307 1296 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1378 1389 1378 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1556 1567 1556 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1667 1678 1667 1678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 725 733 <span type="species:ncbi:9606">patients</span>
###xml 764 772 <span type="species:ncbi:9606">patients</span>
###xml 1156 1164 <span type="species:ncbi:9606">patients</span>
###xml 1679 1687 <span type="species:ncbi:9606">patients</span>
To determine if the different TNFSF15 (TL1A) haplotypes associated with CD in Jewish patients correlate with functional consequences in TL1A expression, we isolated CD14+ monocytes from Jewish and non-Jewish CD patients with haplotypes A or B, and stimulated them with immune complexes (IC), a known inducer of TL1A gene expression [7]. We observed strong induction of TL1A secretion in response to IC in Jewish haplotype B carriers at 6 h of stimulation. Compared to Jewish haplotype A carriers, the secretion was significantly increased at 6 h in haplotype B carriers (Figure 2A). At 16 h we also observed an increase, although not significant (p = 0.22), in secretion of TL1A in haplotype B compared to haplotype A Jewish patients (Figure 2A). In non-Jewish CD patients we also observed a significant difference between TL1A secretion in haplotypes A and B at 6 h of IC stimulation (Figure 2B). Haplotype B carriers secreted significantly more TL1A at 6 h compared to haplotype A carriers. At 16 h the difference in TL1A secretion between the haplotypes were not significant (p = 0.29), although we observed a higher secretion in haplotype B non-Jewish patients. To determine if there are ethnic differences in expression of TL1A we compared Jewish and non-Jewish haplotype B carriers. Jewish haplotype B carriers secreted significant more TL1A at 6 h compared to non-Jewish haplotype B (p = 0.002). At 16 h we did not observe any differences in the IC-induced secretion of TL1A (p = 0.49). Next, we compared the TL1A secretion in Jewish and non-Jewish haplotype A carriers. There were no differences in the IC-induced secretion of TL1A in Jewish or non-Jewish CD haplotype A patients at 6 or 16 h (p = 0.07 and 0.09, respectively).
###end p 37
###begin title 38
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
The B risk haplotype is associated with increased TL1A secretion in CD patients.
###end title 38
###begin p 39
###xml 293 304 293 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 309 320 309 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 429 430 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 434 446 430 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 504 515 500 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 520 531 516 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
Monocytes from Jewish and non-Jewish patients with A, or B haplotypes were stimulated with IC for 6 or 16 h. Cell culture supernatants were analyzed for TL1A secretion by ELISA. (A) Monocytes from Jewish patients with A or B haplotypes were stimulated with IC for 6 or 16 h (n = 15 and 12 for haplotype A and haplotype B, respectively, *, P</=0.002). All data represent the mean+/-SD. (B) Monocytes from non-Jewish patients with A or B haplotypes were stimulated with IC for 6 or 16 h (n = 13 and 15 for haplotype A and haplotype B, respectively, *, P</=0.05).
###end p 39
###begin p 40
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 269 277 269 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g003">Figure 3</xref>
###xml 377 378 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 399 410 399 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 432 443 432 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 454 463 454 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g003">Figure 3A</xref>
###xml 649 650 649 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 676 687 676 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 709 720 709 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 731 740 731 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g003">Figure 3B</xref>
###xml 890 901 890 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 914 925 914 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 987 996 987 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g003">Figure 3C</xref>
###xml 1123 1134 1123 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1147 1158 1147 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1169 1178 1169 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g003">Figure 3D</xref>
###xml 1283 1294 1283 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1366 1377 1366 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1395 1402 1395 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004719-t002">Table 2</xref>
###xml 1425 1436 1425 1436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1501 1512 1501 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1523 1532 1523 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g002">Figure 2C</xref>
###xml 1704 1711 1704 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004719-t002">Table 2</xref>
###xml 1625 1633 <span type="species:ncbi:9606">patients</span>
###xml 1694 1702 <span type="species:ncbi:9606">patients</span>
To determine if the observed differences in TL1A secretion also relate to differences in surface TL1A expression, we determined the expression of membrane TL1A as measured by the percentage of TL1A+ monocytes and mean fluorescence intensity (MFI) after IC stimulation (Figure 3). We did not observe any significant differences in the percentage of control or IC-stimulated TL1A+ monocytes in Jewish haplotype B carriers compared to haplotype A carriers (Figure 3A, p = 0.19 and p = 0.49 for control and IC stimulation, respectively). Furthermore, we also did not observe any significant differences in the percentage of control or IC-stimulated TL1A+ monocytes in non- Jewish haplotype B carriers compared to haplotype A carriers (Figure 3B, p = 0.83 and p = 0.72 for control and IC stimulation, respectively). When we analyzed MFI of TL1A staining we observed an increase in MFI in Jewish haplotype B compared to haplotype A carriers, although this increase did not reach significance (Figure 3C, p = 0.66 and p = 0.52 for control and IC stimulation, respectively). We did not observe any differences in MFI in non-Jewish haplotype B compared to haplotype A carriers (Figure 3D, p = 0.56 and p = 0.91 for control and IC stimulation, respectively). In summary, Jewish and non-Jewish haplotype B carriers secrete significantly more TL1A in response to IC compared to haplotype A carriers at 6 h (Table 2). Furthermore, Jewish haplotype B carriers secrete significantly more TL1A compared to non-Jewish haplotype B carriers (Figure 2C). In contrast, we did not observe any significant differences in TL1A surface expression in patients with different haplotypes in either Jewish or non-Jewish CD patients (Table 2).
###end p 40
###begin title 41
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haplotype A</italic>
###xml 16 17 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Haplotype A and B have similar TL1A surface expressions in Jewish and non-Jewish CD patients.
###end title 41
###begin p 42
###xml 40 41 40 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 45 57 45 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 205 206 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 235 246 235 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 251 262 251 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 413 414 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 418 430 416 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 496 497 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 527 538 525 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 543 554 541 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 667 668 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 672 684 670 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 793 804 791 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 809 820 807 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 937 938 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 942 954 940 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 1064 1075 1062 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1080 1091 1078 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 399 407 <span type="species:ncbi:9606">patients</span>
###xml 653 661 <span type="species:ncbi:9606">patients</span>
###xml 923 931 <span type="species:ncbi:9606">patients</span>
(A) Monocytes from Jewish patients with A or B haplotypes were stimulated with IC for 16 h. Monocytes were stained with an anti-TL1A antibody and analyzed by flow cytometry. Data are presented as % of TL1A+ monocytes (n = 11 and 9 for haplotype A and haplotype B, respectively, P = 0.19 and P = 0.49 for control and IC, respectively). All data represent the mean+/-SD. (B) Monocytes from non-Jewish patients with A or B haplotypes were stimulated with IC for 16 h. Data are presented as % of TL1A+ monocytes (n = 14 and 16 for haplotype A and haplotype B, respectively, P = 0.83 and P = 0.72 for control and IC, respectively). (C) Monocytes from Jewish patients with A or B haplotypes were stimulated with IC for 16 h. Data are presented as mean fluorescence intensity (MFI) (n = 11 and 9 for haplotype A and haplotype B, respectively, P = 0.66 and P = 0.52 for control and IC, respectively). (D) Monocytes from non-Jewish patients with A or B haplotypes were stimulated with IC for 16 h. Data are presented as mean fluorescence intensity (MFI) (n = 14 and 16 for haplotype A and haplotype B, respectively, P = 0.56 and P = 0.91 for control and IC, respectively).
###end p 42
###begin title 43
###xml 44 56 44 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotypes A</italic>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Summary of significant differences for TL1A haplotypes A and B in CD patients stratified into Jewish and Non-Jewish
###end title 43
###begin p 44
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
, p</=0.05
###end p 44
###begin p 45
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
, p</=0.005
###end p 45
###begin title 46
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 (TL1A)</italic>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
TNFSF15 (TL1A) haplotypes in Jewish OmpC+ IBD patients result in differential TL1A expression in monocytes stimulated with IC
###end title 46
###begin p 47
###xml 46 57 46 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 264 276 264 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotypes A</italic>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 362 373 362 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotype</italic>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 441 450 441 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g004">Figure 4A</xref>
###xml 545 554 545 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g004">Figure 4A</xref>
###xml 637 648 637 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 653 654 653 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 725 726 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 731 742 731 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotype</italic>
###xml 810 821 810 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotype</italic>
###xml 881 882 881 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 917 926 917 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g004">Figure 4B</xref>
###xml 1005 1016 1005 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotype</italic>
###xml 1074 1083 1074 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g004">Figure 4C</xref>
###xml 1334 1345 1330 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotype</italic>
###xml 1372 1383 1368 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1385 1394 1381 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g004">Figure 4D</xref>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 413 421 <span type="species:ncbi:9606">patients</span>
###xml 611 619 <span type="species:ncbi:9606">patients</span>
###xml 703 711 <span type="species:ncbi:9606">patients</span>
###xml 788 796 <span type="species:ncbi:9606">patients</span>
###xml 987 995 <span type="species:ncbi:9606">patients</span>
###xml 1199 1207 <span type="species:ncbi:9606">patients</span>
###xml 1316 1324 <span type="species:ncbi:9606">patients</span>
###xml 1358 1366 <span type="species:ncbi:9606">patients</span>
Since we observed a risk association for TL1A haplotype B in Jewish CD patients, and this association was accentuated in Jewish OmpC+ patients, we subdivided the Jewish patients into OmpC+ and OmpC- patients and analyzed TL1A secretion and membrane expression for haplotypes A and B. We observed a significant increase in TL1A secretion in patients carrying the B haplotype compared to A carriers in Jewish OmpC+ patients in response to IC (Figure 4A). Differences in TL1A secretion were most prominent at 6 h post stimulation compared to 16 h (Figure 4A, p = 0.34). We observed a TL1A response in Jewish OmpC+ patients heterozygous for haplotype A and B that was intermediate between that observed for patients carrying the A and B haplotype, respectively (data not shown). Jewish OmpC- patients carrying the B haplotype also secreted higher levels of TL1A in response to IC than A carriers at 6 h post stimulation (Figure 4B, p = 0.054 for 16 h IC stimulation), while non-Jewish OmpC+ patients with the B haplotype secreted higher levels of TL1A at 16 h post stimulation (Figure 4C, p = 0.14 for 6 h IC stimulation), suggesting different kinetics in the TL1A secretion in Jewish vs. non-Jewish CD patients in response to FcgammaR signaling. We did not observe any differences in TL1A secretion in non-Jewish OmpC- patients with the B haplotype compared to patients with haplotype A (Figure 4D, p = 0.21 for 16 h IC stimulation).
###end p 47
###begin title 48
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 71 78 <span type="species:ncbi:9606">patient</span>
The B risk haplotype is associated with increased TL1A secretion in CD patient subgroups.
###end title 48
###begin p 49
###xml 56 68 56 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotypes A</italic>
###xml 72 73 72 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 123 134 123 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 139 150 139 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 282 293 280 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 297 308 295 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 364 375 362 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 380 391 378 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 471 472 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 476 477 472 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 544 555 540 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 560 571 556 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 651 652 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 656 668 650 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 725 726 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 731 732 725 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
###xml 457 465 <span type="species:ncbi:9606">patients</span>
###xml 637 645 <span type="species:ncbi:9606">patients</span>
(A) Monocytes from Jewish OmpC+ patients homozygous for haplotypes A or B were stimulated with IC for 6 or 16 h (n = 7 for haplotype A and haplotype B, *, P</=0.001). Cell culture supernatants were analyzed for TL1A by ELISA. (B) Monocytes from Jewish OmpC- patients homozygous for haplotype A or haplotype B were stimulated with IC for 6 or 16 h (n = 8 and 5 for haplotype A and haplotype B, respectively, *, P</=0.05). (C) Monocytes from non-Jewish OmpC+ patients with A or B haplotypes were stimulated with IC for 6 or 16 h (n = 4 and 5 for haplotype A and haplotype B, respectively, *, P</=0.05). (D) Monocytes from non-Jewish OmpC- patients with A or B haplotypes were stimulated with IC for 6 or 16 h (n = 9 and 10 for A and B, respectively).
###end p 49
###begin p 50
###xml 119 127 119 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g005">Figure 5</xref>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 259 270 259 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotype</italic>
###xml 301 312 301 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A haplotype</italic>
###xml 365 377 365 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g005">Figure 5A, B</xref>
###xml 438 450 438 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g005">Figure 5C, D</xref>
###xml 676 686 676 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotypes</italic>
###xml 688 700 688 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g005">Figure 5A, B</xref>
###xml 853 864 853 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotype</italic>
###xml 877 878 877 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 889 898 889 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g005">Figure 5A</xref>
###xml 934 943 934 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g005">Figure 5B</xref>
###xml 1081 1082 1081 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1087 1088 1087 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1122 1134 1122 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g005">Figure 5C, D</xref>
###xml 1422 1433 1422 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1505 1516 1505 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1527 1534 1527 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004719-t003">Table 3</xref>
###xml 1572 1573 1572 1573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1660 1671 1660 1671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1716 1727 1716 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1877 1888 1877 1888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotype</italic>
###xml 1919 1930 1919 1930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A haplotype</italic>
###xml 1932 1939 1932 1939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004719-t003">Table 3</xref>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 237 245 <span type="species:ncbi:9606">patients</span>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
###xml 323 331 <span type="species:ncbi:9606">patients</span>
###xml 428 436 <span type="species:ncbi:9606">patients</span>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
###xml 831 839 <span type="species:ncbi:9606">patients</span>
###xml 924 932 <span type="species:ncbi:9606">patients</span>
###xml 1112 1120 <span type="species:ncbi:9606">patients</span>
###xml 1208 1216 <span type="species:ncbi:9606">patients</span>
###xml 1335 1343 <span type="species:ncbi:9606">patients</span>
###xml 1859 1867 <span type="species:ncbi:9606">patients</span>
###xml 1901 1909 <span type="species:ncbi:9606">patients</span>
Next, we analyzed the surface expression of TL1A in Jewish OmpC+ patients with different haplotypes by flow cytometry (Figure 5). We observed a significant increase in the proportion of TL1A+ monocytes in untreated monocytes from Jewish patients carrying the B haplotype compared to patients with the A haplotype in Jewish patients regardless of their OmpC status (Figure 5A, B). Similar differences were not seen in non-Jewish patients (Figure 5C, D, p = 0.37 and p = 0.43 for non-Jewish OmpC+ and non-Jewish OmpC- patients, respectively). Surprisingly, we could not observe any differences in the percentage of monocytes expressing TL1A stimulated with IC between different haplotypes (Figure 5A, B, p = 0.31). However, the mean fluorescence intensity (MFI) was significantly increased in IC stimulated monocytes in Jewish OmpC+ patients carrying the B haplotype compared to A carriers (Figure 5A) but not in Jewish OmpC- patients (Figure 5B, p = 0.35). We did not observe any significant differences in surface expression of TL1A in untreated or IC stimulated monocytes between A and B carriers in non-Jewish patients (Figure 5C, D, p = 0.35 and p = 0.36 for IC-stimulated monocytes from non-Jewish OmpC+ patients, % TL1A+ monocytes and MFI, respectively, and p = 0.68 and p = 0.74 for IC-stimulated monocytes from non-Jewish OmpC+ patients, % TL1A+ monocytes and MFI, respectively). In summary, Jewish OmpC+ and OmpC- haplotype B carriers secrete significantly more TL1A in response to IC compared to haplotype A carriers (Table 3). Furthermore, the proportion of TL1A+ monocytes in untreated monocytes is significantly increased in Jewish OmpC+ and OmpC- haplotype B carriers compared to Jewish OmpC+ and OmpC- haplotype A carriers. Additionally, the MFI of TL1A membrane expression was significantly increased in IC stimulated monocytes in Jewish OmpC+ patients with the B haplotype compared to patients with the A haplotype (Table 3).
###end p 50
###begin title 51
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
The B risk haplotype is associated with an increase in the number of TL1A+ peripheral monocytes in Jewish but not in non-Jewish CD patients.
###end title 51
###begin p 52
###xml 46 47 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 51 63 51 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 304 315 304 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 319 330 319 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 368 369 366 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 439 440 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 444 456 440 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 522 523 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 585 596 581 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 600 611 596 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 690 691 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 695 707 689 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 773 774 767 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 836 847 830 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 851 862 845 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 929 930 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 934 946 928 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotypes</italic>
###xml 1012 1013 1006 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1076 1087 1070 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1091 1102 1085 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
###xml 676 684 <span type="species:ncbi:9606">patients</span>
###xml 915 923 <span type="species:ncbi:9606">patients</span>
(A) Monocytes from Jewish OmpC+ patients with A or B haplotypes were stimulated with IC for 16 h. Monocytes were stained with an anti-TL1A antibody and analyzed by flow cytometry. Data are presented as % of TL1A+ monocytes (left panel) or mean fluorescence intensity (MFI) (right panel) (n = 6, or 7 for haplotype A or haplotype B, respectively, *, P</=0.05 for % TL1A+; *, P</=0.02 for MFI). (B) Monocytes from Jewish OmpC- patients with A or B haplotypes were stimulated with IC for 16 h. Data are presented as % of TL1A+ monocytes (left panel) or MFI (right panel). (n = 9 or 6 for haplotype A or haplotype B, respectively, *, P</=0.05) (C) Monocytes from non-Jewish OmpC+ patients with A or B haplotypes were stimulated with IC for 16 h. Data are presented as % of TL1A+ monocytes (left panel) or MFI (right panel). (n = 5 or 6 for haplotype A or haplotype B, respectively). (D) Monocytes from non-Jewish OmpC- patients with A or B haplotypes were stimulated with IC for 16 h. Data are presented as % of TL1A+ monocytes (left panel) or MFI (right panel). (n = 9 or 11 for haplotype A or haplotype B, respectively).
###end p 52
###begin title 53
###xml 44 56 44 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotypes A</italic>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Summary of significant differences for TL1A haplotypes A and B in CD patients sub-stratified into Jewish OmpC+/OmpC- and non-Jewish OmpC+/OmpC-
###end title 53
###begin p 54
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
, p</=0.05
###end p 54
###begin p 55
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
, p</=0.01
###end p 55
###begin p 56
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
, p</=0.001
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 89 96 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 203 210 203 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
###xml 223 234 223 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
###xml 181 189 <span type="species:ncbi:9606">Patients</span>
###xml 502 510 <span type="species:ncbi:9606">patients</span>
Our findings demonstrate a direct association between genetic variation in the TL1A gene TNFSF15, and the induction of TL1A in Jewish, and particularly in OmpC+ Jewish CD patients. Patients carrying the TNFSF15 (TL1A) risk haplotype B have a significantly increased expression of membrane and soluble TL1A in response to IC. In the current era of finding genetic associations with disease using genome-wide association studies, our report also illustrates that detailed molecular phenotypic studies of patients with particular haplotypes will lead to the discovery of important functional differences that occur as a result of the different haplotypes.
###end p 58
###begin p 59
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
###xml 48 59 48 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 218 237 218 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 haplotype B</italic>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 578 589 578 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 716 723 716 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 811 822 811 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B haplotype</italic>
###xml 875 879 875 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
###xml 885 896 885 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1136 1147 1132 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1160 1171 1156 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1301 1312 1297 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1336 1347 1332 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1484 1491 1480 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004719-t002">Table 2</xref>
###xml 1668 1684 1664 1680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A haplotype B</italic>
###xml 1792 1803 1788 1799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 1973 1984 1969 1980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 1990 1997 1986 1993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004719-t003">Table 3</xref>
###xml 2062 2073 2058 2069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 2277 2288 2273 2284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 2324 2335 2320 2331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 2648 2659 2644 2655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 2746 2749 2742 2745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn1">[5]</xref>
###xml 2751 2754 2747 2750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn2">[7]</xref>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
###xml 484 492 <span type="species:ncbi:9606">patients</span>
###xml 716 723 <span type="species:ncbi:562">E. coli</span>
###xml 789 797 <span type="species:ncbi:9606">patients</span>
###xml 926 934 <span type="species:ncbi:9606">patients</span>
###xml 1037 1045 <span type="species:ncbi:9606">patients</span>
###xml 1287 1295 <span type="species:ncbi:9606">patients</span>
###xml 1449 1457 <span type="species:ncbi:9606">patients</span>
###xml 1564 1572 <span type="species:ncbi:9606">patients</span>
###xml 1578 1585 <span type="species:ncbi:9606">patient</span>
###xml 1755 1763 <span type="species:ncbi:9606">patients</span>
###xml 1778 1786 <span type="species:ncbi:9606">patients</span>
###xml 2048 2056 <span type="species:ncbi:9606">patients</span>
###xml 2310 2318 <span type="species:ncbi:9606">patients</span>
###xml 2488 2496 <span type="species:ncbi:9606">patients</span>
###xml 2630 2638 <span type="species:ncbi:9606">patients</span>
###xml 2737 2745 <span type="species:ncbi:9606">patients</span>
We have previously reported that TNFSF15 (TL1A) haplotype B is associated with a more severe disease phenotype in Jewish patients, as these individuals have a higher frequency of small bowel surgery [15]. Furthermore, TNFSF15 haplotype B is associated with increased risk of CD in Ashkenazi Jews (32% in CD vs. 26% in controls) but with a decreased risk in non-Jewish CD patients (39% in CD vs. 50% in controls) [15]. Here, we extend our findings and demonstrate that Jewish OmpC+ CD patients (a group characterized by more severe disease) have a further increased frequency of haplotype B (also a group characterized by more severe disease) (42% CD OmpC+ vs. 25% CD OmpC-) suggesting that an antibody titer for the E. coli outer membrane porin C (OmpC) increases the risk of CD in Jewish patients carrying the B haplotype. We observed that this hierarchical relationship of TL1A risk haplotype B and OmpC titers in Jewish CD patients also applies to the functional response, e.g. the immune responses to FcgammaR signaling in Jewish CD patients. In both Jewish and non-Jewish CD we observed a significant increase of TL1A secretion in haplotype B compared to haplotype A. However, we observed an earlier onset of TL1A secretion and an overall greater amount of TL1A secretion in Jewish patients with haplotype B compared to non-Jewish haplotype B carriers, suggesting different kinetics in the induction of TL1A expression in Jewish vs. non-Jewish patients carrying haplotype B (see Table 2 for data summary). When we further sub-stratified Jewish and non-Jewish patients into patient groups with or without positive serology for OmpC antibodies, this association of TL1A haplotype B and increased TL1A expression was further accentuated in Jewish OmpC+ patients. Jewish OmpC+ patients with haplotype B have increased secretion of soluble and enhanced expression of membrane TL1A in response to IC, as well as increased baseline membrane TL1A expression, when compared to haplotype A (see Table 3 for data summary). On the other hand Jewish OmpC- patients with haplotype B have increased secretion of soluble TL1A in response to IC, and increased baseline membrane TL1A expression, but TL1A and membrane TL1A in response to IC are not significantly different when compared to haplotype A. In non-Jewish OmpC+ patients with haplotype B, we only observed an increased secretion of soluble TL1A in response to IC, but with a distinct and delayed kinetics compared to Jewish OmpC+ and OmpC- patients of the same haplotype. The higher baseline expression of membrane TL1A on monocytes that we observed in Jewish but not non-Jewish CD patients carrying haplotype B might suggest a higher capacity of TL1A dependent T cell activation in these patients [5], [7].
###end p 59
###begin p 60
###xml 222 235 222 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g005">Figures 5A, B</xref>
###xml 491 500 491 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g002">Figures 2</xref>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g004">4</xref>
###xml 719 735 719 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g004">Figure 4 A and B</xref>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
###xml 407 415 <span type="species:ncbi:9606">patients</span>
###xml 481 489 <span type="species:ncbi:9606">patients</span>
###xml 570 578 <span type="species:ncbi:9606">patients</span>
###xml 652 660 <span type="species:ncbi:9606">patients</span>
###xml 842 850 <span type="species:ncbi:9606">patients</span>
###xml 937 945 <span type="species:ncbi:9606">patients</span>
###xml 1086 1094 <span type="species:ncbi:9606">patients</span>
Interestingly, we observed that the percentages of monocytes with TL1A surface expression being approximately twice as high in OmpC- Jewish patients compared to OmpC+ patients for either haplotype when stimulated with IC (Figures 5A, B). We analyzed the TL1A surface expression of monocytes in response to IC stimulation at a 16 h time-point. We have demonstrated that monocytes from Jewish OmpC+ and OmpC- patients have a faster induction of TL1A secretion compared to non-Jewish patients (Figures 2, 4). We observed maximal induction of TL1A secretion in Jewish OmpC+ patients at 6 h and a decline of TL1A secretion at 16 h. However, in Jewish OmpC- patients we observed a further increase of TL1A secretion at 16 h (Figure 4 A and B). The mechanism for the differential induction in Jewish OmpC+ vs. Jewish OmpC- and Jewish vs. non-Jewish patients is currently unknown. The differences in surface expression in Jewish OmpC+ vs. OmpC- patients might therefore just reflect the differences in cleavage-kinetics of TL1A from the membrane due to higher turn-over of TL1A in Jewish OmpC+ patients.
###end p 60
###begin p 61
###xml 29 48 29 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 haplotype B</italic>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 234 245 234 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype B</italic>
###xml 290 301 290 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">haplotype A</italic>
###xml 332 342 332 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g002">Figures 2B</xref>
###xml 344 350 344 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004719-g003">3B, 3D</xref>
###xml 1131 1150 1131 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15 haplotype B</italic>
###xml 1251 1255 1251 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 1589 1593 1589 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Picornell1">[15]</xref>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
###xml 269 277 <span type="species:ncbi:9606">patients</span>
###xml 424 432 <span type="species:ncbi:9606">patients</span>
###xml 485 493 <span type="species:ncbi:9606">patients</span>
###xml 595 603 <span type="species:ncbi:9606">patients</span>
###xml 762 770 <span type="species:ncbi:9606">patients</span>
###xml 968 976 <span type="species:ncbi:9606">patients</span>
###xml 1242 1250 <span type="species:ncbi:9606">patients</span>
###xml 1508 1516 <span type="species:ncbi:9606">patients</span>
###xml 1559 1567 <span type="species:ncbi:9606">patients</span>
###xml 1702 1710 <span type="species:ncbi:9606">patients</span>
We previously published that TNFSF15 haplotype B is associated with increased risk of CD in Ashkenazi Jews but with a decreased risk in non-Jewish CD patients [15]. To our surprise, we did not observe a decrease in TL1A expression in haplotype B carriers in non-Jewish patients compared to haplotype A carriers as one would expect (Figures 2B, 3B, 3D). However, from the data presented here we are concluding that Jewish CD patients demonstrate a faster TL1A induction than non-Jewish patients. We observed an increase of TL1A secretion at 16 h compared to 6 h post IC-stimulation in non-Jewish patients suggesting a maximal secretion at 16 h. However, we did not analyze the TL1A secretion beyond the 16 h time-point and it might be possible that in non-Jewish patients the maximal secretion of TL1A is reached beyond 16 h. Therefore, it cannot be excluded that a difference between TL1A secretion in haplotype A and B might occur at a later time-point in non-Jewish patients. Furthermore, based on our data we hypothesize that TL1A is a CD severity more importantly than susceptibility gene. We have previously demonstrated that TNFSF15 haplotype B is associated with increased risk of CD in Jews but with a decreased risk in non-Jewish CD patients [15]. However, when we analyzed haplotype association with disease severity, as measured by clinical parameters (fibrostenosis, internal perforation, perianal penetration, small bowel surgeries), no association was observed between haplotypes in non-Jewish patients but association was observed in Jewish CD patients carrying haplotype B [15]. These data are consistent with our findings of no significant differences in TL1A expression in non-Jewish patients.
###end p 61
###begin p 62
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFSF15</italic>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Barrett1">[14]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Duerr1">[33]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Rioux1">[34]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Consortium1">[35]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Dubinsky1">[36]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Parkes1">[37]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Xavier1">[38]</xref>
###xml 239 243 239 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Taylor1">[39]</xref>
###xml 404 407 404 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Takedatsu1">[8]</xref>
###xml 730 731 726 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 775 776 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 869 870 865 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 886 889 882 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Takedatsu1">[8]</xref>
###xml 373 378 <span type="species:ncbi:10090">mouse</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
The TNFSF15 genetic variation and TL1A functional changes observed here are of importance in the context of the recent demonstration that the IL23R gene is a major determinant of CD susceptibility [14], [33], [34], [35], [36], [37], [38], [39]. In particular, we have been able to demonstrate that TL1A synergizes with IL-23 to induce IL-17 production by CD4+ T cells in a mouse model of chronic colitis [8]. Furthermore, these observations are consistent with the role of TL1A during the development of chronic colitis in mice. We have been able to demonstrate that administration of neutralizing TL1A antibodies not only prevents but also treats established chronic colitis, likely by directly blocking IFN-gamma production by TH1 cells and IL-17 and IL-6 production from TH17 cells, and also by blocking the enhancing effect of TL1A/IL-12 and TL1A/IL-23 on these CD4+ T cell subsets [8]. These data support the notion that TL1A expression is increased during chronic mucosal inflammation and that leads to further activation of TH1 and TH17 cells.
###end p 62
###begin p 63
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TL1A</italic>
###xml 285 288 281 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Prehn2">[7]</xref>
###xml 290 294 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Cassatella1">[40]</xref>
###xml 296 300 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004719-Shih1">[41]</xref>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
###xml 439 447 <span type="species:ncbi:9606">patients</span>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
###xml 649 657 <span type="species:ncbi:9606">patients</span>
In this study, we demonstrated that there is a direct association between genetic variants of the TL1A gene and the induction of TL1A in Jewish CD patients. Since the induction of TL1A gene expression seems to be restricted to stimulation by FcgammaR signaling and/or enteric bacteria [7], [40], [41], blockage of TL1A might have therapeutic benefit in IBD patients without markedly increasing the susceptibility to infection. Defining CD patients by ethnicity, serotyping, and genotyping, will allow us to identify patients with the potential for higher TL1A response to immune complexes and commensal bacteria and hence may well identify those CD patients that would respond best to therapeutic blockade of TL1A function.
###end p 63
###begin p 64
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 83 95 <span type="species:ncbi:9606">participants</span>
We would like to thank IBD patients at Cedars-Sinai Medical Center and other study participants whose contribution made this work possible. The authors would like to thank Teva Pharmaceutical USA (North Wales, PA) for generously providing us with the TL1A antibodies.
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.
###end article-title 66
###begin article-title 67
Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
###end article-title 67
###begin article-title 68
###xml 72 77 <span type="species:ncbi:9606">human</span>
TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells.
###end article-title 68
###begin article-title 69
Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
###end article-title 69
###begin article-title 70
Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.
###end article-title 70
###begin article-title 71
###xml 59 65 <span type="species:ncbi:10090">murine</span>
Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
###end article-title 71
###begin article-title 72
###xml 67 72 <span type="species:ncbi:9606">Human</span>
The T Cell Costimulator TL1A Is Induced by Fc{gamma}R Signaling in Human Monocytes and Dendritic Cells.
###end article-title 72
###begin article-title 73
TL1A (TNFSF15) Regulates the Development of Chronic Colitis by Modulating Both T-Helper 1 and T-Helper 17 Activation.
###end article-title 73
###begin article-title 74
Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation.
###end article-title 74
###begin article-title 75
The TNF-Family Receptor DR3 is Essential for Diverse T Cell-Mediated Inflammatory Diseases.
###end article-title 75
###begin article-title 76
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease.
###end article-title 76
###begin article-title 77
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease.
###end article-title 77
###begin article-title 78
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease.
###end article-title 78
###begin article-title 79
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease.
###end article-title 79
###begin article-title 80
TNFSF15 is an ethnic-specific IBD gene.
###end article-title 80
###begin article-title 81
Association of the DTNBP1 locus with schizophrenia in a U.S. population.
###end article-title 81
###begin article-title 82
Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations.
###end article-title 82
###begin article-title 83
Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations.
###end article-title 83
###begin article-title 84
Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease.
###end article-title 84
###begin article-title 85
A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews.
###end article-title 85
###begin article-title 86
Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis.
###end article-title 86
###begin article-title 87
The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease.
###end article-title 87
###begin article-title 88
Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
###end article-title 88
###begin article-title 89
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
###end article-title 89
###begin article-title 90
Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews.
###end article-title 90
###begin article-title 91
Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews.
###end article-title 91
###begin article-title 92
Illumina universal bead arrays.
###end article-title 92
###begin article-title 93
High-throughput SNP genotyping on universal bead arrays.
###end article-title 93
###begin article-title 94
3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures.
###end article-title 94
###begin article-title 95
Allelic discrimination using fluorogenic probes and the 5' nuclease assay.
###end article-title 95
###begin article-title 96
Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens.
###end article-title 96
###begin article-title 97
###xml 28 44 <span type="species:ncbi:562">Escherichia coli</span>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease.
###end article-title 97
###begin article-title 98
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
###end article-title 98
###begin article-title 99
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis.
###end article-title 99
###begin article-title 100
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.
###end article-title 100
###begin article-title 101
IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease.
###end article-title 101
###begin article-title 102
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.
###end article-title 102
###begin article-title 103
Unravelling the pathogenesis of inflammatory bowel disease.
###end article-title 103
###begin article-title 104
IL23R haplotypes provide a large population attributable risk for Crohn's disease.
###end article-title 104
###begin article-title 105
Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis.
###end article-title 105
###begin article-title 106
Mechanisms of Induction of Inflammatory Bowel Disease Associated Gene TL1A (TNFSF15) By Microbes in Antigen Presenting Cells.
###end article-title 106
###begin p 107
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 107
###begin p 108
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH grants DK056328 (S.R.T.) and DK046763 (S.R.T., J.I.R.) and in part by the Cedars-Sinai Board of Governor's Chair in Medical Genetics (J.I.R.). Genotyping was supported in part by the General Clinical Research Center Genotyping Core (RR000425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 108

